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Background
Cognitive deficits in aging, NPH and Alzheimer's disease
(AD) are exacerbated by compromised neurogenesis in
the dentate gyrus (DG) and subventricular zone (SVZ).
We previously found beta-amyloid (Aβ) retention in cor-
tex and hippocampus of aged rats and diseased humans,
due to greater RAGE and lesser LRP-1 expression of micro-
vascular transporters for Aβ. Now we focus on the periv-
entricular DG and SVZ that harbor stem cells convertible
to new neurons in adults. Working hypothesis: Aβ reten-
tion in neurogenic zones harms neural stem cells, leading
to reduced cognition.
Materials and methods
Brown-Norway/Fischer (B-N/F) rats (3, 12, 20 & 30 mo)
were tested in a Morris water maze (following placement
at 3 starting points along the periphery of a circular water
tank) for the time to reach/climb a platform above water.
In trials 1-15, we determined the latency (sec) required for
rats to mount the platform following placement at the
starting point. For trials 1-6, the platform was visible,
while trials 6-15 involved the new challenge of finding the
submerged platform in the same location. On the final
day (probe trial), time spent in quadrant 4 (former loca-
tion of platform) was measured in the platform absence.
Latency was thus used to evaluate the extent of spatial
memory recall. Animals were then injected with BrdU (50
mg/kg i.p. for 1 hr) and euthanized with pentobarbital to
enable brain sampling for immunohistochemistry (IHC)
and microscopy. Univariate statistics on latency for the
cued (platform visible) and non-cued (platform hidden)
trial hypotheses were done by J. Machan.
Results
There were significantly different (Holm-Bonferroni
adjusted) slopes of mean log (latency) among age groups
for several non-cued trials [p < 0.05 (103 df), 3 vs. 12; 12
vs. 30; 20 vs. 30 mo]. This then points to progressive dec-
rement, with advancing age, in spatial working memory in
B-N/F rats. In DG and SVZ, there was increasing amyloid
burden (Aβ 42) and decreasing BrdU (mitosis) activity
between 3 & 30 mo. Astroglial GFAP increased signifi-
cantly between 12 & 20 mo, whereas microglial OX6 IHC
was enhanced over 20 to 30 mo. Staining of nestin (neural
stem cell marker) peaked at 20 mo, but was reduced at 30
mo. Ependyma dismantling and ventricle enlargement
occurred at 30 mo.
Conclusion
Aged rat CNS at 30 mo resembles NPH/AD. DG & SVZ are
stressed by Aβ burden and inflammation. The diminished
spatial memory prompts potential CSF agent usage to sta-
bilize neurogenesis.
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